| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.611 | 42.564 | 49.959 | 72.972 | 107.221 | 139.869 | 186.986 | 221.419 | 240.568 | 228.108 |
| Total Income - EUR | 28.656 | 42.564 | 49.959 | 72.972 | 107.221 | 139.870 | 190.468 | 221.421 | 240.573 | 228.112 |
| Total Expenses - EUR | 17.630 | 22.137 | 23.751 | 26.028 | 48.608 | 75.550 | 94.847 | 123.528 | 133.289 | 131.607 |
| Gross Profit/Loss - EUR | 11.026 | 20.427 | 26.208 | 46.943 | 58.613 | 64.321 | 95.621 | 97.893 | 107.285 | 96.505 |
| Net Profit/Loss - EUR | 10.167 | 20.008 | 25.159 | 46.214 | 57.541 | 63.199 | 94.043 | 96.023 | 105.376 | 89.799 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Diab Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 44 | 0 | 0 | 0 | 1.031 | 1.366 | 9.564 | 11.163 | 17.896 | 30.413 |
| Current Assets | 22.317 | 32.129 | 29.453 | 52.058 | 59.942 | 72.925 | 93.656 | 41.724 | 111.411 | 119.870 |
| Inventories | 0 | 0 | 0 | 0 | 4 | 26 | 0 | 1.083 | 284 | 0 |
| Receivables | 2.610 | 4.158 | 4.779 | 5.747 | 14.987 | 16.958 | 25.140 | 22.192 | 35.114 | 40.887 |
| Cash | 19.706 | 27.971 | 24.674 | 46.311 | 44.952 | 55.941 | 68.515 | 18.450 | 76.013 | 78.984 |
| Shareholders Funds | 17.282 | 20.096 | 25.196 | 46.250 | 57.588 | 69.644 | 95.570 | 43.966 | 122.839 | 89.847 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.243 | 12.033 | 4.258 | 5.809 | 3.402 | 4.667 | 7.742 | 9.067 | 6.644 | 60.445 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diab Clinique S.r.l.